The inaugural HEMA report: a missed opportunity for comprehensive value assessment
Journal of Comparative Effectiveness Research · 2026-05 · 15 (5)
DOI: 10.57264/cer-2026-0049 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-05. Verfasst von Kimberly Westrich und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Pharmaceutical Council, Washington, DC, 20006, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Pharmaceutical Council, Washington, DC, 20006, USA.
ORCID-Profile: Kimberly Westrich, Tyler D Wagner, Jonathan D Campbell
Zitieren
APA
Westrich, K., Wagner, T. D., & Campbell, J. D. (2026). The inaugural HEMA report: a missed opportunity for comprehensive value assessment. Journal of Comparative Effectiveness Research, 15(5). https://doi.org/10.57264/cer-2026-0049
Vancouver
Westrich K, Wagner TD, Campbell JD. The inaugural HEMA report: a missed opportunity for comprehensive value assessment. Journal of Comparative Effectiveness Research. 2026;15(5). doi:10.57264/cer-2026-0049
BibTeX
@article{Westrich2026,
author = {Westrich, Kimberly and Wagner, Tyler D and Campbell, Jonathan D},
title = {The inaugural HEMA report: a missed opportunity for comprehensive value assessment},
journal = {Journal of Comparative Effectiveness Research},
year = {2026},
volume = {15},
number = {5},
doi = {10.57264/cer-2026-0049}
}
EUVIMED